Vycor Medical, Inc.
VYCO
$0.20
$0.0314.29%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.51% | 13.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.51% | 13.75% | |||
| Cost of Revenue | -23.67% | 4.24% | |||
| Gross Profit | 8.81% | 15.84% | |||
| SG&A Expenses | 17.39% | -1.63% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.20% | -0.89% | |||
| Operating Income | -37.18% | 499.22% | |||
| Income Before Tax | -80.54% | 166.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -80.54% | 166.75% | |||
| Earnings from Discontinued Operations | 94.44% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -79.50% | 161.92% | |||
| EBIT | -37.18% | 499.22% | |||
| EBITDA | -27.49% | 1,906.06% | |||
| EPS Basic | -771.43% | 111.67% | |||
| Normalized Basic EPS | -80.00% | 171.43% | |||
| EPS Diluted | -883.33% | 110.00% | |||
| Normalized Diluted EPS | -75.00% | 157.14% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -13.69% | 15.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||